|
|
|
|
Direct Cost |
Indirect Cost |
|
| 1R01DA064348-01 |
Understanding the Influence of "Natural" Cigarillo Descriptors on Expectancies, Subjective Effects, Smoking Behavior, and Exposure: A human laboratory study |
UNIVERSITY OF NEVADA RENO |
NIDA |
$521,963 |
$117,957 |
$639,920 |
| 1R01DK143049-01 |
Novel Targets for GI Hormones and Neuropeptides in Regulation of Intestinal Motility |
UNIVERSITY OF NEVADA RENO |
NIDDK |
$1,747,480 |
$809,666 |
$2,557,146 |
| 1R01GM158967-01 |
Function and Regulation of Lysine Methylation Dependent Proteolysis |
UNIVERSITY OF NEVADA LAS VEGAS |
NIGMS |
$460,268 |
$219,588 |
$679,856 |
| 1R01HL173789-01A1 |
Improving the efficacy of cell-based cardiac repair |
UNIVERSITY OF NEVADA LAS VEGAS |
NHLBI |
$327,242 |
$167,712 |
$494,954 |
| 1R01HL177084-01A1 |
REGULATION OF CAPILLARY HEMODYNAMICS BY THIN-STRANDED PERICYTES |
UNIVERSITY OF NEVADA RENO |
NHLBI |
$497,848 |
$196,875 |
$694,723 |
| 1R03AA032396-01 |
Assessment of risky drinking typologies among college student alcohol users |
UNIVERSITY OF NEVADA LAS VEGAS |
NIAAA |
$99,357 |
$51,169 |
$150,526 |
| 1R03HD117200-01A1 |
Creating Safe and Equitable Walkability to School: Infrastructure and Policy Readiness |
UNIVERSITY OF NEVADA RENO |
NICHD |
$121,482 |
$32,120 |
$153,602 |
| 1R16GM159134-01 |
Regulation of Hematopoiesis by the EZH2-PRC2 Complex |
UNIVERSITY OF NEVADA LAS VEGAS |
NIGMS |
$100,000 |
$49,582 |
$149,582 |
| 1R16GM159578-01 |
Plasmonic Nanoantenna Enhanced Ultrasensitive Fluorescence Immunoassay Enabled by Super-hydrophobic Surface |
UNIVERSITY OF NEVADA LAS VEGAS |
NIGMS |
$100,000 |
$47,091 |
$147,091 |
| 1R21AI185435-01A1 |
Defining the mechanism of action of the broadly-active antiviral mosquito protein aBravo |
UNIVERSITY OF NEVADA RENO |
NIAID |
$275,000 |
$126,185 |
$401,185 |
| 1R21AI188267-01A1 |
The development and evaluation of portable experimental huts for global malaria vector control decision-making |
UNIVERSITY OF NEVADA LAS VEGAS |
NIAID |
$260,332 |
$106,513 |
$366,845 |
| 1R21AI194218-01 |
Genomic Surveillance of Mpox through the Development of a Wastewater Intelligence Model and Data Analytics Platform |
UNIVERSITY OF NEVADA LAS VEGAS |
NIAID |
$275,000 |
$141,625 |
$416,625 |
| 1R21NS142775-01 |
The Role of Proton-Mediated Signaling at the Neuromuscular Junction in ALS Models |
UNIVERSITY OF NEVADA RENO |
NINDS |
$275,000 |
$112,525 |
$387,525 |
| 1R35GM160285-01 |
Engineering lipid nanoparticle platform for selective and enhanced delivery in vivo |
UNIVERSITY OF NEVADA LAS VEGAS |
NIGMS |
$250,000 |
$125,633 |
$375,633 |
| 1R35GM160474-01 |
Engineering Modular Protein Inhibitors for Selective Targeting of Pathological Biomolecules |
UNIVERSITY OF NEVADA RENO |
NIGMS |
$275,000 |
$125,178 |
$400,178 |
| 1R43AG097283-01 |
Developing Novel Ambroxol Analogs as Disease-Modifying Therapies for Alzheimer's Disease and Related Dementias |
ZYWIE LLC |
NIA |
|
|
$496,600 |
| 1R44AI188872-01 |
High Content Screening for Bifunctional Chimera Biologics |
HELIGENICS INC |
NIAID |
|
|
$807,664 |
| 1R61NS136656-01A1 |
Targeting the ABCA1 cholesterol transporter to correct pathophysiological myelin formation in hereditary neuropathies |
UNIVERSITY OF NEVADA RENO |
NINDS |
$242,499 |
$109,574 |
$352,073 |
| 1RF1NS137980-01A1 |
The relationship between ocus-coeruleus-norepinephrine network and neurovascular coupling in health and disease |
UNIVERSITY OF NEVADA RENO |
NINDS |
$1,914,122 |
$899,637 |
$2,813,759 |
| 1RF1NS143766-01 |
Promoting Engagement and Clinical Trial Readiness for Alzheimer's Disease and Related Dementias Among Underserved Sexual and Gender Minorities |
UNIVERSITY OF NEVADA LAS VEGAS |
NINDS |
$1,718,980 |
$515,211 |
$2,234,191 |